Greenwich LifeSciences (GLSI) Assets Average (2020 - 2026)

Greenwich LifeSciences (GLSI) has 6 years of Assets Average data on file, last reported at $5.0 million in Q4 2025.

• Quarterly Assets Average rose 0.67% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 0.67% YoY) and the FY2025 annual result came in at $5.1 million, down 7.37% from the prior year.
• Assets Average improved to $5.0 million in Q4 2025, from $3.5 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $30.1 million in Q2 2021 to a low of $2.9 million in Q2 2025.
• A 5-year average of $13.6 million and a median of $10.7 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average jumped 60.62% — and 2025, when it sank 53.87%.
• Tracing GLSI's Assets Average over 5 years: stood at $28.1 million in 2021, then plunged by 48.12% to $14.6 million in 2022, then slumped by 44.57% to $8.1 million in 2023, then plunged by 38.56% to $5.0 million in 2024, then grew by 0.67% to $5.0 million in 2025.
• The last three Assets Average figures came in at $5.0 million (Q4 2025), $3.5 million (Q3 2025), and $2.9 million (Q2 2025), per Business Quant data.